Targeting biomolecular condensation and protein aggregation against cancer

JL Silva, D Foguel, VF Ferreira, TCRG Vieira… - Chemical …, 2023 - ACS Publications
Biomolecular condensates, membrane-less entities arising from liquid–liquid phase
separation, hold dichotomous roles in health and disease. Alongside their physiological …

Inhibition of p53 protein aggregation as a cancer treatment strategy

K Kwan, O Castro-Sandoval, C Gaiddon… - Current Opinion in …, 2023 - Elsevier
The p53 protein plays a critical role in the prevention of genome mutations in the body,
however, this protein is frequently mutated in cancer and almost all cancers exhibit …

Treating p53 mutant aggregation-associated cancer

M Kanapathipillai - Cancers, 2018 - mdpi.com
p53 is a tumor suppressor protein. Under stressful conditions, p53 tightly regulates cell
growth by promoting apoptosis and DNA repair. When p53 becomes mutated, it loses its …

Targeting the prion-like aggregation of mutant p53 to combat cancer

JL Silva, EA Cino, IN Soares, VF Ferreira… - Accounts of chemical …, 2018 - ACS Publications
Conspectus Prion-like behavior of several amyloidogenic proteins has been demonstrated
in recent years. Despite having functional roles in some cases, irregular aggregation can …

Aberrant phase separation and cancer

K Taniue, N Akimitsu - The FEBS journal, 2022 - Wiley Online Library
Eukaryotic cells are intracellularly divided into numerous compartments or organelles, which
coordinate specific molecules and biological reactions. Membrane‐bound organelles are …

Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands

EC Petronilho, MM Pedrote, MA Marques… - Chemical …, 2021 - pubs.rsc.org
Mutant p53 tends to form aggregates with amyloid properties, especially amyloid oligomers
inside the nucleus, which are believed to cause oncogenic gain-of-function (GoF). The …

Biomolecular condensates and their links to cancer progression

D Cai, Z Liu, J Lippincott-Schwartz - Trends in biochemical sciences, 2021 - cell.com
Liquid–liquid phase separation (LLPS) has emerged in recent years as an important
physicochemical process for organizing diverse processes within cells via the formation of …

A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer

JJ Miller, C Gaiddon, T Storr - Chemical Society Reviews, 2020 - pubs.rsc.org
Referred to as the “guardian of the genome”, p53 is the most frequently mutated protein in
cancer and almost all cancers exhibit malfunction along the p53 pathway. As an …

Mesoscopic protein-rich clusters host the nucleation of mutant p53 amyloid fibrils

DS Yang, A Saeedi, A Davtyan… - Proceedings of the …, 2021 - National Acad Sciences
The protein p53 is a crucial tumor suppressor, often called “the guardian of the genome”;
however, mutations transform p53 into a powerful cancer promoter. The oncogenic capacity …

Intrinsically disordered proteins and biomolecular condensates as drug targets

M Biesaga, M Frigolé-Vivas, X Salvatella - Current Opinion in Chemical …, 2021 - Elsevier
Intrinsically disordered domains represent attractive therapeutic targets because they play
key roles in cancer, as well as in neurodegenerative and infectious diseases. They are …